Pretraživanje
Prikaz rezultata 1-1 od 1
Is endocan a novel potential biomarker of liver steatosis and fibrosis? / Da li je endokan novi potencijalni biomarker za steatozu i fibrozu jetre?
(Belgrade: Society of Medical Biochemists of Serbia, 2020)
Studies that evaluated endocan levels in nonalcoholic fatty liver disease (NAFLD) and liver fibrosis are scarce. We aimed to explore endocan levels in relation to different stages of liver diseases, such as NAFLD, as ...